MedTrace Logo

BlueWind Medical Reprieve System for the Treatment of PNP

NCT02062398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-12-30

Study results available
· View outcomes & findings →

Summary

The current study will evaluate the safety and performance of the BlueWind Medical Reprieve System for the treatment of Chronic Painful Peripheral Neuropathy.

Conditions

Interventions

DEVICE

The Reprieve System

BlueWind Medical neurostimulator for the treatment of neuropathic pain

Sponsors & Collaborators

  • BlueWind Medical

    lead INDUSTRY

Principal Investigators

  • Jean Pierre Van Buyten, MD · Sint-Niklaas hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Belgium
  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062398 on ClinicalTrials.gov